The cell-barriers are essential for the maintenance and regulation of the microenvironments of the human body. Cell-penetrating peptides have simplified the delivery of bioactive cargoes across the cell plasma membrane. Here, the passage of three cell-penetrating peptides: transportan and the transportan analogue, transportan 10, and penetratin, across a Caco-2 human colon cancer cell layer in vitro was investigated. The peptides were internalised in the epithelial Caco-2 cells as visualised by indirect fluorescence microscopy and quantified by fluorometry. Studies of peptide outflow from cells show that the peptides were in equilibrium across the plasma membrane. Moreover, the ability of the peptides to cross a Caco-2 cell layer was tested in a two chambered model system. After 120 min, 7.0%, 2.8% and 0.6%, respectively, of added transportan, transportan 10 and penetratin were detected in the lower chamber. However, both transportan and transportan 10, reversibly decreased the transepithelial electric resistance (TEER) of the barrier model with a minimum after 60 min with 46% and 60% of control, respectively. Penetratin did not affect the cell layer to the same extent. Although, transportan markedly increased the passage of ions, the paracellular flux of 4.4 kDa fluorescein labelled dextran was limited. In conclusion, the obtained results indicated that the transportan peptides passed the epithelial cell layer mainly by a mechanism involving a transcellular pathway.
INTRODUCTION
High resistance epithelial/endothelial cell barriers restrict passage of various hydrophilic compounds, from the intestine and the circulating blood, into the human body. The high resistance is due to the formation of well-organised tight junctions (TJs) that connect the cell plasma membranes via a network of apical localised seams. As the name implies, TJs exclude paracellular passage of ions, peptides and proteins (for review see [1, 2] ).
Today, there are several cell culture models for studying transport across tight junction barriers and in this study we have used the widely applied human epithelial Caco-2 cells.
These cells in a two chamber system are considered a model for predicting drug adsorption as reviewed in [3] .
There are several shortcomings of the techniques applied for the delivery of hydrophilic therapeutic agents over a cellular barriers in vivo, such as that they are invasive and have low yield of delivery [4, 5] . Cell-penetrating peptides (CPPs) [6] , a new type of cellular delivery agents, may prove to be a new and improved technique for delivery over a cell-barrier. To address this possibility, we asked the question if CPPs would be as useful for delivery across a cell barrier, as they have been proven to be in translocating across the cell plasma membrane.
Transportan is a 27 amino acid long chimeric peptide containing the N-terminal 12 amino acids of the neuropeptide galanin and the wasp venom mastoparan (Table 1. ). The Lys 13 residue was introduced to make labelling and cargo attachment convenient. Transportan has been shown to successfully deliver peptides, peptide nucleic acids (PNA) and proteins into several different cell types [7, 8] . The internalisation of transportan is protein independent and, hence, is not mainly mediated through the endocytotic pathway [7] .
A number of transportan analogues have been synthesised so far and the most promising carrier candidate among them is transportan 10, TP10, where 6 of the N terminal amino acids have been deleted [9] (Table 1 ). The well-characterised CPP penetratin [10, 11] was included throughout this study for comparison (Table 1) . Transportan, transportan 10 and penetratin are representatives from two structurally divergent families of cell-penetrating peptides [12] .
To our knowledge, this is the first study investigating the use of CPPs as potential carriers of therapeutics across an in vitro epithelial barrier. A recent study by Violini et al. studied the passage of Tat fragment (48-60) across Caco-2 cells [13] . However, the Tat peptide's ability added to the upper Transwell chamber. At each time point, a 150 µl sample was collected from the lower chamber and replaced by fresh HKR. The fluorescence was measured at 320/420 nm (Abz) and 492/520nm (fluorescein) on a Spectramax Gemini XS (Molecular Devices, CA).
In addition, all experiments have been performed at 20 µM peptide concentration, however, these data has been omitted from the graphs for clarity. The peptide degradation studies in cells and in conditioned media by MALDI-TOF mass spectrometry was performed as described earlier [15] .
As control experiment, the passage of the peptides was performed with the exact set up as the cell layer passage but without the Caco-2 cells. This was carried out in order to quantify how much the transwell filter would limit the passage of the peptides.
Cellular penetration studies and fluorescence microscopy
The cells were grown on round glass cover slips (12 mm, GTF, Sweden) in a 24-well plate to approximately 50 % confluence. The media was changed to serum free and the biotinylated 
Membrane disturbance assay
The efflux of radioactivity from cells preloaded with tritiated 2-deoxyglucose in the presence of peptide was measured according to the method described previously [16] 
RESULTS

Fluorescence microscopy of cell-penetration in Caco-2 cells
Transportan, TP10 and penetratin entered Caco-2 cells at both 37 °C ( Fig. 1 ) and 4°C (data not shown). Furthermore, addition of the endocytosis inhibitor phenylarsine oxide (25µM)
[17] did not change the uptake of the peptides to any visible extent ( Fig.1 B, D, F and H). The transportan peptides localised in the nuclear membrane and also in the nucleus and yield a diffuse staining throughout the cytoplasm. The staining of biotinylated penetratin differ, the nuclear staining was punctuate and the membrane was not stained to the same extent as for the transportan peptides, as observed in the microscope.
The cellular uptake of the CPPs in this study is not temperature-dependent, which exclude uptake merely by endocytosis [18] . This is in correlation with earlier data where both peptide families, as well as other CPPs, have been shown to enter several different cell lines in a temperature-independent manner (for review see [6] ).
Quantification of cellular uptake and outflow
Outflow studies were performed to determine the ability of cell-penetrating peptides to exit cells. A trypsin wash of the cells was included to discriminate between cell-associated (available for degradation) and internalised peptide (not available for degradation). Already after 15 min (data not shown) 30% of the added transportan and 10% of the added TP10 were found inside the cells, this was also shown at 30 min ( For this purpose biotinyl-transportan was added in combination with Abz-labelled penetratin.
Surprisingly, only a minor effect (from 0.6 ± 0.3% to 1.0 ± 0.1 % of added penetratin) in penetratin passage could be detected (Fig. 4) .
Passage of Abz labelled peptides over the transwell filter
To further control the data of peptide passage across the cell-layer in the Transwel, peptide passage was performed without cells in the well. The filter in the Transwell is made of polycarbonate with 0.4µm pores and the apical side of this filter was coated with human fibronectin as described in the experimental procedures.
After 120 min, 1.4% and 2.6%, of the added transportan and transportan 10 were found in the lower chamber, respectively (Table 2 ). For comparison, 1.8 % of added penetratin was found to cross the filter of the Transwell. Of the added reference compound, FITC-dextran, 70 % was found in the lower chamber after 120 min (data not shown). The passage was measured in the same manner as described for the cell layer passage.
To analyse the peptide passage, the values from the filter passage was treated as baseline values to the cell layer peptide passage (see Fig.5 ). Unexpectedly, transportan passage was found to be five times higher through the cell layer than through the polycarbonate filter; TP10 displays a non cell dependent passage, while for penetratin the cell layer restricts the passage.
Stability of the peptides
The major peak in the mass spectra, after 180 min in extracellular serum free media in contact with adhesive Caco-2 cells, corresponds to the intact peptides MW. Penetratin is quickly degraded probably due to its many dibasic cleavage sites. However, after 4 h of incubation, the intact peptides were still detectable in cell lysates (data not shown), showing that the peptides are only partly degraded during this time, for both transportan and TP10 at least ten degradation products were found. As published previously [9] , the identified products would be inactive in cell penetration. 
Effect of the peptides on the plasma membrane
Several CPPs have been shown to be toxic most likely due to disturbance of the plasma membrane at higher peptide concentrations [22] . To assess the membrane disturbance of the peptides used in our experiments on Caco-2 cells, the glucose analogue 2-deoxyglucose which is taken up into cells by glucose transporters and is phosphorylated inside the cells by hexokinase, was used. The product, 2-deoxy-D-[1-3 H]-glucose 6-phosphate (DGP) cannot leave the cell via the plasma membrane [23] . Thus, the efflux of radioactivity from cells preloaded with tritium labelled 2-deoxyglucose requires some form of membrane disturbance.
After 30 min of treatment, at 10 µM peptide concentration there is no effect on the leakage of DGP, but at 20 µM, both transportan and TP10 treated cells only retain around 70% radioactivity, while penetratin caused lower leakage and retained 87% (Table 2 ). This is in agreement with previous findings [15] [24] .
DISCUSSION
According to Lipinski´s rules, drugs which are characterised with a logarithm of the partition coefficient octanol/buffer (log p) between -1 and 5, Mw around 500 Da, donate 5 or less hydrogen bonds and accept 10 or less hydrogen bonds, are more likely to be absorbed from the intestine and "have better permeation" [25] . The cell-penetrating peptides in this study deviate from Lipinski´s rules, both concerning the Mw (2430-3070 Da) and number of possible hydrogen bonds. However, CPPs have clearly been demonstrated to enter a vast variety of cell types and in this study we show that CPPs also have the potential to be used for delivery across a cell layer. Moreover, the peptides log p values seems to be in relation to the percentage of peptides that traverse the Caco-2 cell layer (Table 1 and 2).
Transportan has previously been shown to be in equilibrium over the plasma membrane of Bowes cells [7] . Here we show that this is also true for Caco-2 cells (Fig 2) . of several CPPs, such as transportan and TP10, they may interact with intracellular structures [26] which could explain the accumulation inside the cells. This also clarifies why the nonamphipatic penetratin is not retained inside cells but rather "washed-out" [26] . In contradiction to this, only a low percentage (0.6%) of added penetratin transit the polarised Caco-2 cell layer in the barrier model.
To further investigate penetratin´s contradicting behaviour in outflow and cell layer passage, we studied the peptide flow over fibronectin coated Transwell membrane without cells and compared it with the peptides´ passage over the cell layer. As expected, penetratin and dextran crossed the naked filter to a higher extent than the cell layer, however, the transportan peptides behaved differently; TP10 was found in comparable amounts in the lower well regardless of cells, while transportan crossed the cell layer in 5 times higher amount with the cell barrier present (Fig. 5) . One could speculate that the cellular accumulation of transportan, seen in the outflow study, would lead to a large increase in peptide concentration close to the filter, which could aid the peptides across the polycarbonate filter. We had expected a correlation of peptide outflow and cell layer passage, but this was not the case as penetratin had the highest rate of outflow (lowest retainment) but the lowest, percentage of peptide added, found in the acceptor chamber.
If the low passage of the peptides across the transwell filter was interpreted as peptide binding to the coated filter, penetratin has high affinity for the filter. This would explain the low passage also when co-added with transportan. However, transportan is also limited by the filter and was, in contradiction to penetratin, conveyed by the cells, possibly through the great accumulation intracellularly, see Fig.5 . Moreover, the efficiency of the passage of peptides correlates with the order of stability. This may play a part for the low yield of penetratin passage, which could explain the biphasic behaviour apparent after 30 min, in Fig.5 .
In addition, when the cells where exposed to 20 µM peptide, the same percentage of added peptide was detected in the lower chamber (data not shown) which argues for an equilibriumlike behaviour of the peptides, not only over the plasma membrane but also over the cell layer.
Furthermore, intestinal cells express peptide transporters that could increase the uptake from the apical side. However, as these transporters typically import smaller peptides [21] , and as
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the CPPs are imported at 4°C imply that transporters are probably not important in this process.
The increase in paracellular ion flux, as measured by TEER, induced by transportans is reversible. It reaches maximal effect after 1h and is nearly reversed after 2 h (Fig. 3 B) , and fully reversed at 4.5 h (data not shown).
Although transportan markedly increases the ion passage (TEER), the paracellular flux of 4.4 kDa fluorescein-labelled dextran is still limited. This is in agreement with Ranaldi et al.
and references therein, who also noted that at least a 50% decrease in TEER is necessary for increased Inulin (5000 Mw) passage [27] .
The increase in TEER indicates a break up of tight junctions [3] while the adherens junctions may be intact, thus limiting the paracellular passage of larger molecules such as dextran and peptides. Yet, when cells treated with transportan for 1 h, which is the time-point when the resistance is at its minimum, were stained for the tight junction marker occludin, no visible break up of the junctions could be detected ( Fig. 6 C and D) . This implies that the effect seen with transportan treatment leaves the junctions more or less intact. Hence, the still limited dextran flux [27] .
Fluorescence staining with rhodamine labelled phalloidin, revealed a marked reorganisation of actin filaments when Caco-2 cells where treated with transportan peptides (Fig. 6 ). The long vertical stress fibres were thicker and more pronounced as compared to untreated cells. Furthermore, the actin reorganisation was most distinct in the cells with the highest peptide staining. One could speculate that the close relation between cell adhesion plaques and the actin cytoskeleton [28] may provide an explanation for the decrease in barrier resistance in cell layers treated with transportans. Penetratin, in comparison, did not reorganise the actin filaments, and were at all time points comparable to control cells (data not shown). Therefore the effect on actin is not an unspecific effect of CPPs, but related to the biological activities of the transportans, such as inactivation of ATPases [7] or GTPases [29] .
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